JAMA Cardiology

JAMA Cardiology
Title	JAMA Cardiology
Discipline	Cardiology
Abbreviation	JAMA Cardiol.
Publisher	American Medical Association
Country	United States
Frequency	Monthly
History	2016–present
Impact	39.0
Impact-year	2023

JAMA Cardiology is a peer-reviewed medical journal focused on cardiovascular medicine, clinical cardiology, and translational cardiovascular science. Launched by the American Medical Association in 2016, the journal publishes original research, reviews, clinical trials, guidelines, and opinion pieces relevant to practitioners and researchers in cardiology, cardiovascular surgery, and preventive medicine. Its articles often intersect with topics covered by New England Journal of Medicine, The Lancet, Circulation (journal), European Heart Journal, and specialty societies such as the American College of Cardiology.

History

The journal was established in 2016 during a period of expansion of specialty titles by the American Medical Association, following precedents set by longstanding journals like JAMA (journal), JAMA Internal Medicine, and JAMA Pediatrics. Its founding coincided with contemporary developments in cardio‑oncology, structural heart interventions exemplified by the PARTNER Trial, and the growth of transcatheter therapies associated with centers such as Cleveland Clinic and Mayo Clinic. Early editorial initiatives reflected debates seen at conferences like the American Heart Association Scientific Sessions and collaborations with registries such as the National Cardiovascular Data Registry.

Scope and Content

The journal covers clinical trials, randomized controlled trials resembling PROVE-IT TIMI 22 and device studies akin to the SENTINEL Trial, observational cohort studies from networks including Framingham Heart Study and Multi-Ethnic Study of Atherosclerosis, mechanistic research that intersects with laboratories like those at Johns Hopkins University and Harvard Medical School, and guideline discussions linked to organizations like the European Society of Cardiology and the World Heart Federation. Content spans acute coronary syndromes informed by registries such as the Get With The Guidelines initiative, heart failure research related to trials like PARADIGM-HF, arrhythmia studies overlapping with AFFIRM (trial) and device therapy research featuring institutions such as Massachusetts General Hospital. The journal also publishes perspectives on public health efforts exemplified by campaigns from Centers for Disease Control and Prevention and policy analyses touching on agencies like the Food and Drug Administration.

Editorial Leadership and Peer Review

Editorial leadership has included editors and associate editors with affiliations to institutions such as Yale School of Medicine, Stanford University School of Medicine, and University of Pennsylvania Perelman School of Medicine. The peer-review process follows standards similar to those of International Committee of Medical Journal Editors and draws reviewers from professional societies including the American College of Cardiology and the Heart Rhythm Society. Editorial decisions often reflect evidence-gathering approaches used in systematic reviews associated with groups like the Cochrane Collaboration and methodology developed in trials registered with ClinicalTrials.gov.

Abstracting and Indexing

The journal is indexed in major bibliographic databases such as Index Medicus, MEDLINE, and PubMed Central, and is included in citation services like Web of Science and Scopus. Bibliometric tracking aligns with metrics reported by Journal Citation Reports and alternative metrics captured by services like Altmetric (company), with coverage that supports inclusion in institutional repositories at universities including Columbia University and University of California, San Francisco.

Impact and Reception

The journal has been cited in clinical guidelines produced by the American College of Cardiology and referenced in policy discussions involving the Centers for Medicare & Medicaid Services. Influential articles have contributed to practice changes analogous to those resulting from the COURAGE trial and have been discussed at major meetings such as the European Society of Cardiology Congress. Reception in the clinical community has been compared with specialty titles like Circulation: Heart Failure and Heart (British Cardiac Society journal), and the journal's editorial content has prompted commentary in outlets including The New York Times and professional newsletters from organizations like the American Heart Association.

Access and Publication Model

Published monthly by the American Medical Association, the journal follows a hybrid open access model familiar to publishers such as Elsevier and Springer Nature, offering traditional subscription access as well as options for open access publication. Authors may comply with funder mandates from agencies like the National Institutes of Health by depositing manuscripts in repositories such as PubMed Central after embargo periods. The journal implements policies on conflicts of interest in line with statements from the International Committee of Medical Journal Editors and adheres to reporting guidelines like CONSORT and PRISMA for clinical trials and systematic reviews, respectively.

Category:Cardiology journals Category:American Medical Association